Mario Sznol

Professor, Internal Medicine

Yale University Yale Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Georgina V. Long

University of Sydney

AUSTRALIA

View details

David Chen

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Aaron Newman

Assistant Professor

Stanford University

UNITED STATES

View details

Delvys Rodriguez-Abreu

Universidad de Las Palmas de Gran Canaria

SPAIN

View details

Ana Arance

University of Barcelona

SPAIN

View details

Helen Gogas

Head, Professor in Medical Oncology,

National and Kapodistrian University of Athens

GREECE

View details

Shahneen Sandhu

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mario Sznol

Research Interests

Explore related searches

Contact this professor

Articles (10)

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy

Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

CD4 T cells and toxicity from immune checkpoint blockade

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma

Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications

Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis

Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study

Collaborators (7)

Georgina V. Long

David Chen

Aaron Newman

Delvys Rodriguez-Abreu

Ana Arance

Helen Gogas

Shahneen Sandhu

Make your next move.